Video

Educated Patient® Prostate Cancer Summit: September 26, 2020

Author(s):

CURE staff

View the full CURE® Educated Patient® Summit on Prostate Cancer here!

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Watch the full CURE® Educated Patient® Summit on Prostate Cancer​ for an insightful discussion with multiple experts from the prostate cancer field. Topics covered from this summit include new treatment methods, dealing with side effects of treatment and much more!

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      Image of Dr. Deville.
      What are the Long-Term Side Effects of Proton Therapy in Prostate Cancer?
      Image of Doctor.
      Long-Term Prostate Cancer Data Highlights Risk and Survivorship Needs
      Image of Dr. Tagawa.
      Breaking Down the Benefits of Clinical Trial Participation in Cancer Care
      Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
      Crafting an Individual Treatment Plan for Patients With Prostate Cancer
      Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
      NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery
      Image of smiling doctor.
      Top 3 Takeaways From ASCO GU 2025
      Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
      Emphasizing the Importance of Breast Cancer Education and Screenings
      Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
      The Power of Knowledge and Staying Informed in Breast Cancer Care
      Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
      Xtandi and Talzenna Therapy Shows Responses in Advanced Prostate Cancer
      Image of woman with blonde hair.
      Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
      Related Content
      Itovebi plus Ibrance and Faslodex improved overall survival in patients with HR+, HER2– breast cancer versus placebo: © stock.adobe.com.
      May 22nd 2025

      Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer

      Caroline Seymour
      Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
      Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
      January 30th 2024

      Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

      Alex Biese Brielle Benyon
      Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
      FDA sign.
      May 22nd 2025

      FDA's ODAC Votes Against Targeted Therapies in Bladder and Prostate Cancer

      Ryan Scott
      The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate cancer, respectively.
      CURE Cancer Horizons podcast logo
      January 29th 2024

      Prostate Cancer Headlines, CAR-T Warnings and Laughter Therapy

      Alex Biese Brielle Benyon
      CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.
      Man and doctor.
      May 20th 2025

      Prostate Cancer Treatment Options: Common Questions in Focal Therapy, Surgery

      Kristie L. Kahl
      Dr. Kelly Stratton answered the most frequently asked questions in prostate cancer regarding localized prostate cancer care, including surgery and focal therapy.
      Dr. Kelly Stratton answers the most frequently asked questions in prostate cancer regarding risk for recurrence, progression and treatment options: © stock.adobe.com.
      May 19th 2025

      Answers to Frequently Asked Questions About Prostate Cancer Risk, Treatment

      Kristie L. Kahl
      Dr. Kelly Stratton answers the most frequently asked questions in prostate cancer regarding risk for recurrence, progression and treatment options.